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Abstract
Background: Ozonated autohemotherapy (OA) has been previously successfully used in the treatment of patients
affected by peripheral occlusive arterial disease. OA consists of an intrafemoral reinfusion of autologous blood
previously exposed to a mixture of oxygen/ozone (O2/O3). This study analyzes the effects of OA in protecting rat
kidney from ischemia and ischemia/reperfusion damage.
Methods: We performed OA 30 min before the induction of 60 min renal ischemia or at the induction of 60 min
postischemic reperfusion in rats subjected to unilateral nephrectomy. In addition, to evidence the possible
protection induced by O2/O3 on endothelial functions, the present study analyzes the in vitro effects of O2/O3 on
oxygen consumption by human umbilical vein endothelial cells (HUVEC).
Results: 1) OA preserves rat kidney functions and architecture, as demonstrated by the improved levels of serum
creatinine and blood urea nitrogen and by histology; 2) such protection does not correlate with the increase of
plasmatic nitric oxide, but is compatible with a focal renal increase of renal bNADPH-diaphorase; 3) treatment of
HUVEC with O2/O3 significantly increases both the rate of oxygen consumption and the mitochondrial activity
assessed by confocal microscopy.
Conclusion: The preservation of the mitochondrial activity of endothelium could in vivo limit the endothelial
dysfunction provoked by the Isc or Isc/R processes.
Background
The controversial debate on the beneficial versus the
toxicological actions of ozone (O3), is still open [1].
However, if O3 is judiciously used within the precisely
determined therapeutic window, it does not cause toxic
effects [2-4]. Few relevant clinical applications demon-
strate that Oxygen-Ozone (O2/O3) autohemotherapy
(OA, i.e. slow re-infusion of autologous blood previously
exposed to a O2/O3 mixture), is useful in cardiovascular
disorders and tissue ischemia, as well as supportive in
viral infections through stimulation of the immune sys-
tem [1,2]. In patients with peripheral occlusive arterial
disease, OA improves hemorheological parameters and
O2 delivery to tissues. [3]. Moreover, OA improves the
capability of erythrocytes to deliver O2 to ischemic tis-
sues, and finally induces a localized release of protective
nitric oxide (NO), CO and growth factors from platelets
[1,2].
Ischemia (Isc) and Ischemia/Reperfusion (Isc/R)-
related injuries are major causes of acute kidney injury
following renal transplantation. Despite tolerance induc-
tion, long-term surviving kidney allografts can develop
chronic damages [4,5]. Among the O2-based methods,
O2/O3 preconditioning, i.e. intra-peritoneum injection of
O2/O3 mixture before ischemic damage, is an efficient
protective system from rat Isc/R in both liver [6] and
kidney [7,8]. In the renal model, O2/O3 preconditioning
increases the expression of endothelial and inducible
forms of NO synthase (eNOS, iNOS, respectively), and
the NO release [9], with a mechanism similar to that
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induced by Isc preconditioning. The latter is an experi-
mental model of brief, sequential ischemic events, that
results in protecting against subsequent ischemic epi-
sodes. In comparison with both Isc and O2/O3 precon-
ditioning, OA could have the considerable advantage of
being feasible in humans. In our knowledge, no clinical
or experimental data are presently available on OA role
in protecting from renal Isc/R injury. Aim of the present
study was to investigate if OA could be proposed to
improve renal damage following Isc and Isc/R, in com-
parison with O2 alone.
Endothelial cells have been proposed to be elective
targets of the positive molecular effects of ozone and its
derived species formed during blood ozonation [10]. As
mechanism of action, we have hypothesized that O2/O3
could locally increase the O2 availability for endothelial
cells, supporting their resistance to dysfunction, thus
contributing to protection of organs from Isc/R damage.
Indeed, we evaluated: the effects of OA on renal mor-
phology and function in rats subjected to Isc or Isc/R;
plasmatic nitric oxide (NO) levels and renal iNOS iso-
form expression, because of the cytoprotective role of
NO in Isc/R [11,12]. The effects of O2/O3 on endothe-
lium were also investigated on rat renal arteries through
expression of CD31/PECAM1, and in vitro through
measurements of O2 consumption, mitochondrial oxida-
tive activity and cell metabolism.
Methods
Animals
Male adult Wistar rats (Harlan Italy, S.Pietro al Nati-
sone, Udine, Italy), 230-250 g, were used. The rats had
free access to standard pelleted food and water and
were maintained at temperature of 22 ± 1°C with a 12 h
light/dark cycle. All experimental procedures conformed
to the “guide for the care and the use of Laboratory
Animals published by the US National Institute of
Health (NIH publication NO: 85-23, revised 1996),
according to the animal welfare regulations of the Italian
local authorities (Ethical Committee of the University of
the Studies of Milan, Italy).
Experimental groups
We submitted rats to Isc followed by brief R time,
because kidney damages occur early during R and pre-
vious authors already studied the effects of ozone-oxida-
tive preconditioning after long R time [7-9]. Moreover,
we submitted rats to unilateral nephrectomy to avoid
the controlateral kidney influence before to induce Isc.
The rats were randomly assigned to 8 groups (n = 7
rats/group). All the rats were treated with autologous
blood groups 1 to 8 by intrafemoral injection. Groups 1
and 5 were unoperated (e.g. controls); groups 2 and 6
sham operated (e.g. rats undergoing the surgical
procedure without clamp of the left renal artery); groups
3 and 7 were ischemized (Isc); groups 4 and 8 were
ischemized and reperfused (Isc/R). In groups 2 to 4 and
6 to 8 the rats underwent right kidney nephrectomy
before any other treatment. In groups 1, 2, 3, 4. autolo-
gous blood was treated with O2 alone. In groups 5, 6, 7,
8 autologous blood was treated with O2/O3 mixture
(OA) Intrafemoral injection of autologous blood or OA
was performed 30 min before the rat killing in groups 1
and 5, or 30 min after right kidney removal in groups 2
and 6, respectively. Groups 3 and 7 received a single
intrafemoral injection of the blood 30 min before Isc
(indeed underwent Isc). Groups 4 and 8 received a sin-
gle intrafemoral injection of the blood at the time of
clamp removal (e.g. at R). Sampling was performed after
60 min reperfusion. The characteristics of the different
groups are reported in Table 1.
Isc/R model
Rats were anesthetized inhaling a mixture of halothane
2% (Hoechst, Milano, Italy) in oxygen. They were placed
on a temperature-regulated table (38°C) (Ugo Basile,
Comerio, Lecco, Italy) to maintain body temperature.
Isc was induced in kidneys by clamping the left renal
artery and the left renal vein for 60 min with a micro-
surgical clamp. R was obtained by removing vascular
clamp and lasted 60 min. During the surgical procedure
heart rate and mean arterial blood pressure were moni-
tored. At the end of Isc or of Isc/R, rats were exangui-
nated at the aorta bifurcation level, blood samples were
recovered, and kidneys were collected from 4 animals/
group and processed for histological analysis. During the
surgical procedure the heart rate and the mean arterial
blood pressure were monitored, as previously described
[13].
Ozonated autohemotherapy
First of all we set up the optimal O2/O3 concentration.
An ozone generator (Multiossigen, Gorle, Bergamo,
Italy) was used to erogate the O2/O3 gas mixture, com-
posed of an equivalent volume of ozone-oxygen (1:1
Table 1 Experimental groups of rats
GROUPS O2/O3 AUTOHEMOTHERAPY
GROUP 1 CONTROLS - 30’ before killing
GROUP 2 “SHAM OPERATED” - 30’ after right kidney removal
GROUP 3 Isc - 30’ before Isc
GROUP 4 Isc/R - at R
GROUP 5 CONTROLS + 30’ before killing
GROUP 6 “SHAM OPERATED” + 30’ after right kidney removal
GROUP 7 Isc + 30’ before Isc
GROUP 8 Isc/R + at R
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volume relationship). Ozone concentration in the mix-
ture was 50 μg/ml, per ml of blood, known to not cause
oxidative injury in vivo [14]. Rat blood (1 ml) was drawn
from the caudal vein into a sterile glass tube; and 20 μl
heparin (5000 U.I./ml, Vister, Parke-Davis, Lainate,
Milano, Italy) was used as an anticoagulant. Tube was
connected to the ozone generator and 1 ml blood ex
vivo exposed to 5 ml of gas mixture. During the expo-
sure to the gas mixture (4 min) blood was continuously
and gently shaken until it appeared light red, then was
re-infused into the left femoral vein of the donor rat.
No other medication was given. Autohemotherapy with
the administration of medical oxygen was performed as
a control treatment.
Functional studies
Serum creatinine was measured using a modified Jaffe’s
reaction and blood urea nitrogen was measured on the
AEROSET system (Abbott Laboratories, Abbott Park,
IL) [13].
Histopathology of rat kidneys
Collected kidneys were fixed and processed as pre-
viously described [15]. Renal damage was evaluated on 4
to 6 sections stained with Hematoxylin/Eosin as tubular
epithelial cell necrosis, tubular dilation, protein casts
and medullary congestion. The alterations were semi-
quantitatively graded (- = absent, + = barely present, ++
= moderate, +++ = severe) [16] instead of being sub-
mitted to statistical analysis, which was scarcely reliable
in our conditions. Additional 4 to 6 sections from O2/
O3-treated rats were submitted to bNADPH diaphorase
for evaluating NOS activity. In fact bNADPH diaphorase
histochemistry reflects the expression of total NOS in
the rat kidney tissue [17]. Slides were incubated with 1
mM bNADPH/0.2 mM nitroblue tetrazolium/100 mM
Tris-HC1 buffer pH 8.0 containing 0.2% Triton X-100
for 60 min at 37°C as described [13]. A pathologist who
worked blindly analyzed the sections using Eclipse 55i
microscope equipped with a DS-L1 camera (Nikon,
Tokyo, Japan).
Nitrite/Nitrate determination
At the end of Isc and of Isc/R, 1 ml of heparinized (not
coagulated) blood was drawn at the aorta bifurcation of
each rat to measure the NO concentrations. Blood sam-
ples underwent centrifugation and plasma aliquots were
stored at -21°C until determination. Plasma nitrite/
nitrate were determined using the Greiss reaction that
measures combined oxidation products of NO, plasma
nitrite (NO2
-) and nitrate (NO3
-) after reduction with
nitrate reductase in a colorimetric assay [18]. Standard
curves with increasing concentrations of sodium nitrate
and sodium nitrite were run in parallel.
Isolation and culture of HUVEC
Human umbilical vein endothelial cells (HUVEC) were
isolated from human cord by collagenase treatment as
described [19] and cultured in 1% gelatin-coated flasks
(Falcon; Becton Dickinson, Bedford, MA, USA) using
endotoxin-free Medium 199 (BioWhittaker, Cambrex
Bio Science Verviers, Belgium), containing 20% heat-
inactivated fetal bovine serum (FBS, Hyclone, Logan,
UT, USA), 1% bovine retinal-derived growth factor, 90
μg/ml heparin, 100 I.U./ml penicillin, and 100 μg/ml
streptomycin (Biochrom, Berlin, Germany). All experi-
ments were carried out with HUVEC at passage 1-4.
O2 consumption by HUVEC
Consumption of O2 was measured using the Biological
Oxygen Monitor System 5300A (YSI Incorporated, Yel-
low Springs, Ohio, USA) and Clark-type-polarographic
O2 electrode. The data were recovered with Win-
Wedge software (TAL Technologies, Philadelphia, PA,
USA).
During O2 consumption measurements, the cells were
placed in thermostatically-regulated chambers (37°C)
equipped with a magnetically stirred circulator. The
instrument calibration was performed considering the
levels of O2 as 24% (= μl of O2/ml, corresponding to the
volume of O2 dissolved in aqueous medium at 1 atm
and 37°C) [20]. O2 consumption values were recorded
every 5 sec for 15 to 60 min. After 5 min of acclimatiza-
tion, O2/O3 mixture was added in about 10 seconds (2
ml, at the ozone concentration of 50 μg O3/ml) through
a PE 50 polyethylene tube [21].
Measure of ATP and LDH levels in HUVEC
Measure of oxygen consumption in HUVEC has been
associated to the dosage of adenosine 5’ triphosphate
(ATP) and lactate dehydrogenase (LDH). Briefly,
HUVEC seeded on 6 well and 24 well plates respec-
tively, were exposed to the O2/O3 mixture (2 ml at the
concentration of 1 μl/ml) for about 2 minutes; after
that, ATP and LHD contents were measured at different
time intervals (e.g. 5, 30, 60, 90, 120 min). The assays
were performed in quadruplicate. ATP luminescence
assay kit (Invitrogen, San Giuliano Milanese, Milano,
Italy) and LDH assay kit (Cytotoxicity Colorimetric
assay kit, Oxford Biochemical Research INC, Oxford,
MI, USA) have been used. ATP levels have been
referred to HUVEC protein content, whereas LDH to
the volume (ml) of cell suspension.
HUVEC protein content assay
Cell protein content has been measured by the colori-
metric method, using Coomassie brilliant blue G-250
(BioRad Laboratories, Richmond, CA, USA). Cells were
previously lysated as described in the manifacture
Foglieni et al. BMC Nephrology 2011, 12:61
http://www.biomedcentral.com/1471-2369/12/61
Page 3 of 11
protocol. Bovine serum albumin was used as standard
(BioRad protein assay).
Confocal microscopy on HUVEC
Mitochondria and nuclear activities were labeled on liv-
ing HUVEC, grown on glass coverslips (105 cells/cover-
slip) with mitoTraker CMX-ROS (250 nM, 40 min, 37°
C) (Molecular Probes, Eugene, OR) and with acridine
orange (Sigma-Aldrich, St. Louis, Missouri) [17], prior
to insufflate cells with 1 ml O2/O3. mixture.
Time-course confocal microscopy was performed
using a Leica TCS SP2 AOBS (Leica Microsystems
GmbH, Wetzlar Germany) confocal microscope. Free
projection max (FPM) images were obtained from single
channels-collected Z-series, acquired before the O2/O3
treatment, at the moment of O2/O3 addition (t 0), after
5, 10, 20, 30, 60, 120, 180 min (t 1-t 7) from O2/O3
addition. Single-channel FPM were merged with Adobe
Photoshop CS.
Statistical Analysis
Results were expressed as the mean ± SEM. We per-
formed Student’s t test to analyse the distribution of the
groups. Indeed, we performed Kolmogorov-Smirnov test
and ANOVA test to analyse the differences between
groups; p values less than 0.05 were considered significant.
Results
In the rats studied the heart rate did not significantly
vary during the experimental procedure, whereas mean
arterial pressure significantly increased during ischemia
(data not shown) [13]. Post-surgery polyuria or oliguria
were not evidenced.
OA improves renal dysfunction induced by both Isc and
Isc/R
We compared renal functions of rats subjected to O2 and
O2/O3 autohemotherapy (A vs. B, Table 1). Both Isc and
Isc/R significantly increased serum creatinine and blood
urea nitrogen levels in respect to controls and sham-oper-
ated animals. Notably, pre-treatment with OA (group B)
protected kidneys from damage due to Isc or Isc/R, keep-
ing serum creatinine and blood urea nitrogen at values
comparable to those measured in controls and in sham-
operated rats, but significantly lower than Isc- and Isc/R-
induced animals, not submitted to OA (Figure 1).
OA protects kidneys from histological damages inflicted
by Isc and Isc/R
Tubular alteration is commonly considered an indicator
of Isc renal damage, and alterations in intrarenal micro-
circulation and O2 handling can contribute to organ
dysfunction, leading to Isc-related acute kidney injury
[7,11]. Early alteration of peritubular capillary blood
flow during reperfusion has been previously related to
loss of normal endothelial cell function and Isc precon-
ditioning prevents endothelial dysfunction [22,23].
Histological findings were summarized in Table 2 and
Figure 2. Kidneys from Isc- and Isc/R- submitted rats
displayed tubular necrosis, medullary congestion and
glomerular damages in comparison to kidneys from con-
trol and sham-operated rats, accordingly with our pre-
vious findings [13]. In particular, focal glomerular
damage, i.e. persistence of protein casts engulfing glo-
merular capillaries and Bowman spaces, was observed in
Isc/R animals. OA treatment was able to reduce this
tubulo-medullary damages, in particular preserved glo-
merular morphology.
OA effects on: nitrite/nitrate, bNADPH-diaphorase, iNOS,
CD31/PECAM1
As expected, both Isc and Isc/R significantly decreased
plasmatic nitrite/nitrate levels. OA did not significantly
affect these levels (Figure 3A). Endothelial damage was
investigated locally, through the expression of the endothe-
lial marker CD31/PECAM1 in renal tissue. Its bright
expression was evident on endothelial cells of cortical arter-
ioles (Figure 3B) from OA-treated Isc/R rats at a level com-
parable to control animals, and to a lesser extent in OA-
treated Isc rats. In animals not submitted to OA, a faint sig-
nal was detected in Isc/R and no label in Isc. Overall, these
results indicate an endothelial alteration when rats under-
going Isc or Isc/r did not receive OA. Consistently, the
inducible isoform of NOS, iNOS (Figure 3C), appeared
focally and weakly expressed on glomerular capillaries of
Isc, but not Isc/R rats in the absence of OA. In OA-treated
rats iNOS was weak in Isc/R, but intense in Isc on glomer-
ular capillaries, suggesting an activation of iNOS by OA
treatment. Some CD31/PECAM1 was focally observed into
glomerular capillaries, mostly in controls animals.
The isoform non-specific NOS activity, evaluated by
bNADPH-diaphorase histochemistry, which indicated
bNADPH oxidation in the renal tissue (Figure 3D),
showed a decrease of both glomerular and tubular signal
in damaged areas of the cortex, and of tubular activity in
the medulla of Isc animals as compared to controls. This
focal loss was more evident in the absence than in the
presence of OA. Of note, areas of bNADPH-diaphorase
intense signal were observed in the less injured cortical
regions of Isc rats renal cortex. In kidney of rats sub-
mitted to OA an increase with respect to controls of tub-
ular signal was observed in the cortex and in the medulla.
O2/O3 mixture improves O2 consumption of HUVEC via
increase of mitochondrial activity
HUVEC in basal conditions displayed poor O2 con-
sumption. Administration of O2/O3 mixture early
increased O2 disposal, that was rapidly consumed
Foglieni et al. BMC Nephrology 2011, 12:61
http://www.biomedcentral.com/1471-2369/12/61
Page 4 of 11
Figure 1 Effect of ozonated autohemotherapy on renal function after Isc and Isc/R. The rats received an intrafemoral injection of their
blood driven from caudal vein and treated with O2 or a mixture of O2/O3; the injection was performed 30 min before Isc or at the induction of
post-Isc R. Serum creatinine and blood urea nitrogen levels were measured. Isc and Isc/R rats subjected to O2/O3 autohemotherapy showed
significant reductions of serum creatinine and blood urea nitrogen levels as compared with animals subjected to O2 autohemotherapy.
Abbreviations: C = controls rats, Sham = sham-operated rats, Isc = rats submitted to 60 min of ischemia by clamping the renal artery; Isc/R =
rats submitted to 60 min of ischemia followed by 60 min reperfusion. *p < 0.05
Table 2 Histopathology of rat kidneys
Group Tubular necrosis Tubular dilation Protein casts Medullary congestion Glomerular damage Interstitial stasis
1 control - - - - - -
A 2 sham-operated - - - - - +/-
3 Isc - + + +/++ - ++
4 Isc/R + ++ +++ + - +
5 control - - - - - -
B 6 sham-operated - - - - - +/-
7 Isc + - +/- + + ++
8 Isc/R + + ++ +/+/- + +
(A) Autologous blood + O2
(B) Autologous blood + O2/O3
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(Figure 4A). The total amount of O2 consumed by O2/
O3-treated HUVEC in 10 min, increased six-fold in
comparison with untreated cells (Figure 4B). Confocal
microscopy of HUVEC, 2 min after addition of the O2/
O3 mixture (t0), showed a marked increase of both
mitochondrial activity and Acridine orange signal as
compared to basal fluorescence (Figure 4C panels a, b).
Changes are compatible with the increased intracellular
bioavailability of O2 suggested by the rapid rise in O2
consumption (Figure 4A). The effect reverted slowly to
basal after 30 min from O2/O3 exposure (Figure 4C
panel c). Confocal analysis performed 3h after O2/O3
exposure, demonstrated that HUVEC mitochondrial
activity and Acridine orange signal were comparable to
basal (data not shown), thus indicating the absence of
metabolic degeneration following the treatment.
OA increases ATP production, without affecting LDH, in
HUVEC
After brief O2/O3 exposure, HUVEC were maintained in
culture for up to 2 h. Total cellular ATP content,
expressed in pmol/mg cellular protein, significantly
increased at 30 and 60 min (Figure 5, upper panel)
whereas LDH levels, expressed in U/ml, did not signifi-
cantly vary (Figure 5, lower panel). ATP significantly
increased 30 min after O2/O3 exposure, in agreement
with the increase in mitochondrial activity (Figure 4C),
suggesting that OA improves mitochondrial function.
Discussion
The main objective of this study is to investigate if the
OA, which is used in patients affected by PAOD, could
be proposed as a possible method to reduce damage due
to Isc and/or postischemic R. We tested our hypothesis
in vivo using an experimental model of Isc and Isc/R in
rat kidney and in vitro using the possible target of Isc
damage, e.g. HUVEC. In the present work blood sam-
ples were exposed to a mixture of O2/O3, , and then re-
infused in the donor rat, and compared to that exposed
to O2 alone before re-infusion. The advantages of our
proposed therapy over preconditioning is to reduce the
number of treatments in the time and to permit a more
direct availability of ozone to the Isc organ due to intra-
venous treatment. We raised the question whether the
Figure 2 Histological features of kidneys from rats submitted to O2 or toO2/O3 autohemotherapy. Hematoxylin/Eosin stain of sections
from control and sham operated rats show that surgical treatment did not affect normal renal morphology displayed by histologic findings
(upper row images). Isc and Isc/R, in the presence of O2 therapy, dramatically altered the tubular and glomerular architectures and viability
(middle and lower rows, left images). The O2/O3 autohemotherapy reduced the entity of alterations, especially the tubular damage and
congestion of the medulla (middle and lower rows, right images) (original magnification x200).
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Figure 3 Effect of O2/O3 therapy on plasmatic nitrite/nitrate and renal iNOS activity. In panel A are reported plasmatic nitrite/nitrate levels;
the mean values/group of animals obtained by Greiss colorimetric assay are expressed in micromoles/L. Rats subjected to Isc or Isc/R that
received or not O2/O3 autohemotherapy showed reduced levels of NO as compared with corresponding controls C. Abbreviations: Sham =
sham-operated rats. Isc = ischemia; Isc/R = ischemia/reperfusion. *p < 0.05. Panels B, C show iNOS (green) and CD31 (red) expression by
confocal microscopy on representative sections from renal cortex of rats treated with OA (+O2/O3) or not. Renal arterioles (panel B) display no
iNOS. CD31 is bright comparably to control (cfr.with panel C, upper left) on the arteriolar endothelial lining of Isc/R +O2/O3 rats only. Glomeruli
display an increased iNOS in Isc animals, brighter in rats +O2/O3 than in the others. Very faint iNOS is focally observed in sections from the
untreated controls and in Isc/R +O2/O3. In panel D the renal bNADPH diaphorase oxidative activity is shown as blue formazan signal on kidney
sections. No difference in the renal cortex signal was seen between presence or absence of OA, but Isc animals display an inhomogeneous loss,
whereas Isc/R an increase of the tubular signal respect to controls. Conversely medullary tubular cells of Isc and Isc/R rats submitted to OA show
an higher bNADPH diaphorase signal than all the others.
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Figure 4 Oxygen consumption and mitochondrial activity by HUVEC. Panel A shows the O2 consumption of HUVEC measured by means of
a Clark electrode. After a brief termic acclimatization, 2 ml of O2/O3 mixture containing 50 μgO3/ml was gently added to HUVEC medium (time
0). Two min after the addition of O2/O3, the availability of oxygen increased around twofold. The rate of oxygen consumption significantly
increased with respect to basal conditions (cells untreated with O2/O3 mixture). The histogram in panel B compares total O2 consumed in 10
min in basal conditions and after the addition of the O2/O3 mixture, displaying a 6 times increase in O2 consumption for HUVEC treated with
O2/O3 . Confocal microscope 2D pictures of HUVEC labeled with mito Traker CMX-ROS red and Acridine Orange green are represented in panel
C. Image b, compared with image a, which shows the basal signal, displays an increase in both signals paralleling the infusion of O2/O3 at time
0. Image c demonstrates that the increase in mitochondrial respiration and in nuclear activity reverts to basal activities after 30 min from O2/O3
addition.
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OA was effective in the protection against damage due
to renal Isc/R, often provoked in patients by athero-
sclerotic renal artery stenosis.. Since the damage due to
R is very early [23], we decided to use a short time of
reperfusion (e.g. 1 h), also in consideration that some
other previous works [7,9] have already reported the
usefulness of O2/O3 treatment at longer reperfusion
times. Our results show that OA significantly improves
kidney functional parameters compromised by Isc and
Isc/R. In fact, increases of serum creatinine and blood
urea nitrogen levels are significantly reduced following
OA (Figure 1). Histology shows that OA significantly
reduces medullary congestion and tubular dilation pro-
voked by Isc and Isc/R, and only slightly reduces protein
casts (Figure 2 and Table 2). However, the protection on
the renal function induced by OA does not correlate
with an increase in NO production. An activation of
iNOS by OA treatment is shown the alteration of NO/
NOS pool occurring after Isc injury may play a protec-
tive or a damaging role. The analysis of the bNADPH
diaphorase shows that the OA increases the enzyme
activity in the cortical tubules and in the glomeruli of
the kidney, only after Isc, suggesting an increase in NO
local production following the blood supply
Figure 5 ATP and LDH levels in HUVEC at different times from exposure to O2/O3 mixture. The data represent the m ± SEM of 4
experiments. *P < 0.05 vs NT (not treated), e.g. not exposed to O2/O3 mixture.
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interruption. In rat kidneys, increased glomerular
bNADPH diaphorase, e.g. local synthesis of NO, after
renal Isc, seems to be a protective mechanism that
counteracts vasoconstrictor and inflammatory phenom-
ena occurring during the R period. However, as pre-
viously reported, since Isc/R injury can activate
inflammatory reactions, Isc/R-induced renal NO level
may be related to a increase of nuclear factor kappa B-
dependent pro-inflammatory factors, which play a major
role in the activation of iNOS during the inflammatory
process [24]. Moreover, increased NO in reperfused kid-
ney might be greatly enhanced by a simultaneous
increase in superoxide radicals [25]. In our experimental
model OA seems to be protective against Isc/R injury
via NO generation.
Endothelial injury occurs rapidly after an ischemic insult
[23] and relates to reduced mitochondrial activity [15].
Because Krebs cycle and mitochondrial mass are early vic-
tims of endothelial dysfunction [26], to better evidence the
possible influence of O2/O3 treatment on the modulation
of endothelial dysfunction, we have determined the mito-
chondrial functions of HUVEC through their capability to
consume O2. Recently, it has been demonstrated that
decrease in O2 consumption by pulmonary artery
endothelial cells from patients affected by idiopathic pul-
monary arterial hypertension was related to a decreased
mitochondrial activity for these cells [27]. Previously, the
effect of ozonated serum on HUVEC has been investigated
and a dose-dependent increase of hydrogen peroxide as
the main mediator of ozone action (possibly through an
increase of NO production) was shown [28]. In our experi-
ments, HUVEC display a low rate of oxygen consumption
in basal conditions. The addition of O2/O3 mixture signifi-
cantly increases the oxygen availability and the rate of oxy-
gen consumption (Figure 4A and 4B). In parallel, confocal
microscopy evidences a marked increase of mitochondrial
activity, as revealed by mito Traker (Figure 4C, red signal).
We can argue that, whereas in basal conditions ATP is
generated nearly equivalently by glycolysis and cellular
respiration [27], O2/O3 treatment stimulates the mito-
chondrial energetic metabolism of HUVEC, as shown,
within 30-60 min, by a significant increase in ATP levels.
Because in the same time intervals LDH levels of HUVEC
do not significantly vary, the increase of ATP is attributa-
ble to the increase of mitochondrial instead of glycolytic
pathway. Indeed, the O2/O3 mixture could restore the
energy production also in vivo, when the reduction of
available O2 due to Isc impairs endothelial cell respiration,
favouring only their glycolytic activity. ATP reverted to
basal levels after 90 min exposure to O2/O3 mixture, indi-
cating that the shift from glycolytic to mitochondrial path-
way, induced by O2/O3 treatment, was transient and fully
reversible.
Injured endothelial cells reduce mitochondrial func-
tions [26]. Since O2/O3 treatment improves endothelial
respiration, with a more elevated production of ATP, we
can argue that O2/O3 could preserve endothelial cells
from dysfunction. Collectively, our results are the first
evidence on OA mechanism of action on cell
metabolism.
Conclusions
The preservation of endothelial metabolic activity could
in vivo limit endothelial dysfunction provoked by the Isc
or Isc/R processes. Because AO but not autohemother-
apy with O2 alone is able to reduce endothelial dysfunc-
tion caused by Isc/R, we hypothesize that O3, which is
endowed with anti-inflammatory properties, could limit
the endotehlial activation provoked by some pro-inflam-
matory cytokines released during Isc/R processes.
Finally, since Isc and Isc/R damages represent complica-
tions in atherosclerotic processes, we propose OA as a
promising intervention in atherosclerotic patients.
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